| Treatment resistance in obsessive-compulsive disorder R Middleton, MG Wheaton, R Kayser, HB Simpson Treatment resistance in psychiatry: risk factors, biology, and management …, 2019 | 26 | 2019 |
| Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder D Pagliaccio, R Middleton, D Hezel, S Steinman, I Snorrason, ... Proceedings of the National Academy of Sciences 116 (41), 20346-20353, 2019 | 25 | 2019 |
| Resilience predicts positive mental health outcomes during the COVID-19 pandemic in New Yorkers with and without obsessive-compulsive disorder DM Hezel, AM Rapp, MG Wheaton, RR Kayser, SV Rose, GR Messner, ... Journal of psychiatric research 150, 165-172, 2022 | 21 | 2022 |
| Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation: a randomized clinical trial EB Foa, HB Simpson, T Gallagher, MG Wheaton, M Gershkovich, ... JAMA psychiatry 79 (3), 193-200, 2022 | 15 | 2022 |
| Integrating exposure and response prevention with a mobile app to treat obsessive-compulsive disorder: feasibility, acceptability, and preliminary effects M Gershkovich, R Middleton, DM Hezel, S Grimaldi, M Renna, ... Behavior Therapy 52 (2), 394-405, 2021 | 15 | 2021 |
| Utilizing exposure and response prevention to address poor insight in obsessive-compulsive disorder RR Middleton, DM Hezel Journal of Cognitive Psychotherapy 33 (3), 213-227, 2019 | 8 | 2019 |
